Chronic Plaque Psoriasis Completed Phase 2 Trials for E-6201 (DB11687)

IndicationStatusPhase
DBCOND0033442 (Chronic Plaque Psoriasis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00539929Paired-Comparison Study Evaluating the Efficacy and Safety of E6201 Versus Vehicle for the Treatment of Plaque-Type PsoriasisTreatment